ConductScience.org, home

Paper31769737

In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model.

Williams IP and 12 others. MAbs, 2020. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model. Papers, record 31769737. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31769737

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model.
PubMed
Journal
MAbs
PubMed
Year
2020
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
0.84
iCite
Revised in PubMed
2026-01-27
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Williams IPIwan Phttps://orcid.org/0000-0002-3471-4664
2Crescioli SSilvia
3Sow HSHeng Shenghttps://orcid.org/0000-0003-4143-7543
4Bax HJHeather J
5Hobbs CCarl
6Ilieva KMKristina M
7French EElise
8Pellizzari GGiulia
9Cox VVivienne
10Josephs DHDebra H
11Spicer JFJames F
12Karagiannis SNSophia Nhttps://orcid.org/0000-0002-4100-7810
13Mele SSilviahttps://orcid.org/0000-0003-3709-5739

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Antineoplastic Agents, ImmunologicalMajor topic
Chondroitin Sulfate ProteoglycansMajor topic
Immunoglobulin EMajor topic
Membrane ProteinsMajor topic
Recombinant Fusion ProteinsMajor topic
Animals
Antibody-Dependent Cell Cytotoxicity
Cell Line, Tumor
Cross Reactions
Female
Humans
Immunization, Secondary
Immunocompetence
Mice
Rats
Chondroitin Sulfate Proteoglycan 4

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
MR/L023091/1Medical Research CouncilUnited KingdomPubMed
C30122/A15774Cancer Research UKUnited KingdomPubMed
C30122/A11527Cancer Research UKUnited KingdomPubMed

Source PubMed

Download CSV of grants

References59

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129360527Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncology.J Allergy Clin Immunol2018https://conductscience.org/library/papers/29360527PubMed
219767073Elevated serum cytokines during human anaphylaxis: Identification of potential mediators of acute allergic reactions.J Allergy Clin Immunol2009https://conductscience.org/library/papers/19767073PubMed
39816036Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.Clin Cancer Res1995https://conductscience.org/library/papers/9816036PubMed
421569129
Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity.
Clin Exp Allergy2011https://conductscience.org/library/papers/21569129PubMed
522692757Using the allergic immune system to target cancer: activity of IgE antibodies specific for human CD20 and MUC1.Cancer Immunol Immunother2012https://conductscience.org/library/papers/22692757PubMed
631217827Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma.Ther Adv Med Oncol2019https://conductscience.org/library/papers/31217827PubMed
715531878Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron.Nature2004https://conductscience.org/library/papers/15531878PubMed
821913827Analysis of patient survival in a Phase I trial of systemic targeted α-therapy for metastatic melanoma.Immunotherapy2011https://conductscience.org/library/papers/21913827PubMed
925197555Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells.J Immunother Cancer2014https://conductscience.org/library/papers/25197555PubMed
1020406069Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury.Biomark Med2010https://conductscience.org/library/papers/20406069PubMed
1110903725Expression of a functional Fc epsilon RI on rat eosinophils and macrophages.J Immunol2000https://conductscience.org/library/papers/10903725PubMed
1220395199A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas.Cancer Res2010https://conductscience.org/library/papers/20395199PubMed
1315824037Differential arterial/venous expression of NG2 proteoglycan in perivascular cells along microvessels: identifying a venule-specific phenotype.Microcirculation2005https://conductscience.org/library/papers/15824037PubMed
1428526770Therapeutic IgE Antibodies: Harnessing a Macrophage-Mediated Immune Surveillance Mechanism against Cancer.Cancer Res2017https://conductscience.org/library/papers/28526770PubMed
1530956175IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states.EBioMedicine2019https://conductscience.org/library/papers/30956175PubMed
161760821Regression of human melanoma xenografts in nude mice injected with methotrexate linked to monoclonal antibody 225.28 to human high molecular weight-melanoma associated antigen.Cancer Immunol Immunother1991https://conductscience.org/library/papers/1760821PubMed
1731024519Biomarkers in Human Anaphylaxis: A Critical Appraisal of Current Evidence and Perspectives.Front Immunol2019https://conductscience.org/library/papers/31024519PubMed
189700724Tumor-specific IgE-mediated inhibition of human colorectal carcinoma xenograft growth.Oncol Res1998https://conductscience.org/library/papers/9700724PubMed
1923594731A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy.BMC Cancer2013https://conductscience.org/library/papers/23594731PubMed
2028096174Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 Signaling.Cancer Res2017https://conductscience.org/library/papers/28096174PubMed

See all 59 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
41672926AllergoOncology in Review: Harnessing Allergy in the Field of Oncology to Improve Patient Outcomes.Clin Exp Allergy2026https://conductscience.org/library/papers/41672926PubMed
41288857IgE based therapeutics are an emerging modality in cancer treatment.Discov Oncol2025https://conductscience.org/library/papers/41288857PubMed
40082557Human CSPG4-targeting CAR-macrophages inhibit melanoma growth.Oncogene2025https://conductscience.org/library/papers/40082557PubMed
39934835An IgE antibody targeting HER2 identified by clonal selection restricts breast cancer growth via immune-stimulating activities.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/39934835PubMed
39833133Physiochemical and functional evaluation of the first-in-class anti-cancer IgE antibody drug, MOv18, through process development and good manufacturing practice production.MAbs2025https://conductscience.org/library/papers/39833133PubMed
39409881Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma.Cancers (Basel)2024https://conductscience.org/library/papers/39409881PubMed
38533720Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma.Expert Rev Clin Immunol2024https://conductscience.org/library/papers/38533720PubMed
38132155Therapeutic Monoclonal Antibodies against Cancer: Present and Future.Cells2023https://conductscience.org/library/papers/38132155PubMed
37491373Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial.Nat Commun2023https://conductscience.org/library/papers/37491373PubMed
37185332Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4.Nat Commun2023https://conductscience.org/library/papers/37185332PubMed
36211808Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies.Oncoimmunology2022https://conductscience.org/library/papers/36211808PubMed
35718062A human IgE bispecific antibody shows potent cytotoxic capacity mediated by monocytes.J Biol Chem2022https://conductscience.org/library/papers/35718062PubMed
35433433Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer.Front Oncol2022https://conductscience.org/library/papers/35433433PubMed
34513315In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpart.Oncoimmunology2021https://conductscience.org/library/papers/34513315PubMed
33155272Isotype selection for antibody-based cancer therapy.Clin Exp Immunol2021https://conductscience.org/library/papers/33155272PubMed
33081206IgE Antibodies against Cancer: Efficacy and Safety.Antibodies (Basel)2020https://conductscience.org/library/papers/33081206PubMed
32331483A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing Melanoma.Cancers (Basel)2020https://conductscience.org/library/papers/32331483PubMed

Download CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31769737

GET https://conductscience.org/api/papers/v1/31769737/references?page=2